摘要:
The present invention discloses a pharmaceutical composition that includes rivaroxaban and one or more excipient in a solid dosage form and methods for making the same. Methods for making compositions of the present invention includes powderizing rivaroxaban by centrifugal wet granulation to form compositions suitable for solid oral dosage form. Pharmaceutical dosage forms produced by methods of the present invention are more homogenous, smoother, and have better rheological properties, better compressibility, and much easier to make. They are much lower in cost and also easier to produce at industrial scales.
摘要:
A flash driving apparatus that eliminates the limitation of setting the flash condition as required of the prior art is provided in the utility model, including a power supply, a control IC, a flash member and a switch module, wherein the switch that is connected with the trigging pin TG of the control IC is provided with two or more contacts, and a condition recognizer that will switch into conduction or cutoff according to a given condition is connected between the switch and the trigging pin TG; With this configuration, when the movement of the switch between the two contacts meets the condition set in the condition recognizer, the condition recognizer switches into conduction and sends the trigging signal to the control IC, or alternatively, the condition recognizer switches into cutoff and stops sending the trigging signal to the control IC such that the apparatus produces the effect of flash when the vibration of the switch meets the given condition.
摘要:
The invention relates to a method for detecting a threshold-crossing of a back electromotive force (bemf) measured in one phase of a multiple-phase motor, the one phase being set at a high impedance while at least one other phase is supplied by pulse-width modulation signal. The method includes the step of comparing the bemf with a threshold. The method includes, prior to the step of comparing, the steps of sampling the bemf during on-periods of the pulse-width modulation signal, and holding the bemf during off-periods of the pulse-width modulation signal.
摘要:
A novel solid composition and methods for making and using the solid composition are provided. The solid composition comprises: (a) at least one active agent with a solubility of less than about 0.3 mg/ml in an aqueous solution with a pH of at most about 6.8 at a temperature of about 37° C.; and (b) a hydrophilic polymer matrix composition comprising: i) a hydrophilic polymer selected from the group consisting of METHOCEL™, POLYOX™ WSR 1105 and combinations thereof; and optionally ii) a hydrophobic polymer selected from the group consisting of Ethocel 20 premium; and (c) an alkalizer selected from the group consisting of calcium carbonate, magnesium oxide heavy and sodium bicarbonate; wherein the composition provides at least about 70% release of the active between about 7 to about 12 hours following oral administration.